Utah Medical Products, Inc. (UTMD)

Market Cap	236.18M +17.2%
Revenue (ttm)	36.11M -7.0%
Net Income	10.49M -16.5%
EPS	3.28 -12.4%
Shares Out	3.18M
PE Ratio	22.60
Forward PE	n/a
Dividend	$1.24 (1.67%)
Ex-Dividend Date	Sep 17, 2026

Volume	22,475
Open	74.70
Previous Close	74.75
Day's Range	74.12 - 74.70
52-Week Range	53.66 - 76.89
Beta	0.36
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 22, 2026

About UTMD

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK fee...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 152
• Stock Exchange: NASDAQ
• Ticker Symbol: UTMD
• Website: https://www.utahmed.com

Financial Performance

In 2025, Utah Medical Products's revenue was $38.52 million, a decrease of -5.83% compared to the previous year's $40.90 million. Earnings were $11.29 million, a decrease of -18.65%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 26, 2026

Data Sources Report a data error